Publisher
Springer Berlin Heidelberg
Reference131 articles.
1. Agewall S, Cattaneo M, Collet JP, Andreotti F, Lip GY, Verheugt FW, Huber K, Grove EL, Morais J, Husted S, Wassmann S, Rosano G, Atar D, Pathak A, Kjeldsen K, Storey RF (2013) Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. Eur Heart J 34:1708–1713 (1713a–1713b, ESC Working Group on Cardiovascular Pharmacology and Drug Therapy and ESC Working Group on Thrombosis)
2. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI, AMPLIFY Investigators (2013a) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369:799–808
3. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI (2013b) Apixaban for extended treatment of venous thromboembolism. N Engl J Med 368:699–708 (Investigators P-E)
4. Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M, Caravaggio Investigators (2020) Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med 382:1599–1607
5. Akl EA, Labedi N, Barba M, Terrenato I, Sperati F, Muti P, Schünemann H (2011) Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev 6:CD6650